Get the Stockscreener App
36.91
9.88%
3.32
After Hours:
36.60
-0.31
-0.84%
Grail Inc stock is traded at $36.91, with a volume of 1.11M.
It is up +9.88% in the last 24 hours and up +9.36% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$33.59
Open:
$34.08
24h Volume:
1.11M
Relative Volume:
1.01
Market Cap:
$1.33B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.6097
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
+12.56%
1M Performance:
+9.36%
6M Performance:
-3.63%
1Y Performance:
+174.02%
1-Day Range:
$33.61
$36.97
1-Week Range:
$30.82
$36.97
52-Week Range:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
36.91 | 1.21B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
492.60 | 184.84B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.21 | 142.52B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
642.99 | 51.24B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.75 | 36.42B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.68 | 31.29B | 15.70B | 1.24B | 2.01B | 6.91 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
GRAIL’s Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission - MSN
Is GRAIL LLC affected by consumer sentiment2025 Performance Recap & Daily Entry Point Trade Alerts - خودرو بانک
Will GRAIL LLC benefit from rising consumer demand2025 Earnings Surprises & Growth Focused Entry Point Reports - خودرو بانک
New Highs: Can GRAIL LLC navigate macro headwindsJuly 2025 Snapshot & Long-Term Capital Growth Ideas - خودرو بانک
Is GRAIL LLC stock a value trapWeekly Profit Recap & High Conviction Investment Ideas - خودرو بانک
Is GRAIL LLC a strong candidate for buy and holdJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - khodrobank.com
GRAIL Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Why is GRAIL LLC stock going downMarket Weekly Review & Accurate Entry and Exit Point Alerts - خودرو بانک
Does GRAIL LLC stock benefit from AI growthQuarterly Trade Review & Comprehensive Market Scan Insights - خودرو بانک
Grail Inc’s Earnings Call Highlights Growth and Optimism - MSN
Custom strategy builders for tracking GRAIL LLCEarnings Summary Report & Verified High Yield Trade Plans - Newser
Is now a turning point for GRAIL LLCFed Meeting & Low Drawdown Trading Strategies - Newser
Is GRAIL LLC trending in predictive chart modelsWeekly Risk Summary & Growth Focused Stock Pick Reports - Newser
GRAIL announces inducement grants - Medical Buyer
Is GRAIL LLC stock entering bullish territory2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
How to forecast GRAIL LLC trends using time seriesJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
What’s next for GRAIL LLC stock price2025 Market Sentiment & Free Technical Confirmation Trade Alerts - Newser
How to manage a losing position in GRAIL LLCProfit Target & AI Forecasted Stock Moves - Newser
Custom watchlist performance reports with GRAIL LLC2025 Winners & Losers & Free Safe Capital Growth Stock Tips - Newser
GRAIL: Intriguing Cancer Testing Product Needs More Time And FDA Approval (GRAL) - Seeking Alpha
Chart overlay techniques for tracking GRAIL LLCInsider Selling & Reliable Breakout Stock Forecasts - Newser
GRAIL’s Big Bet On Blood Tests Pays Off—For Now - Finimize
Price action breakdown for GRAIL LLCJuly 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Grail's Inducement Grants and Talent Strategy: A Catalyst for Long-Term Shareholder Value? - AInvest
GRAIL Grants RSUs To 27 New Employees Under Inducement Equity Plan - Nasdaq
GRAIL's Inducement Grants and Executive Compensation Strategy: A Path to Shareholder Value? - AInvest
Grail announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Cancer Detection Company GRAIL Issues 47K Restricted Stock Units to Attract Key New Talent - Stock Titan
GRAIL LLC stock chart pattern explainedBear Alert & Risk Adjusted Buy/Sell Alerts - Newser
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):